Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 6, 2023
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
[ Thu, Apr 06th 2023
] - WOPRAI
Michael Rose Maintained (SNV) at Buy with Decreased Target to $36 on, Apr 6th, 2023
Michael Rose of Raymond James, Maintained "Synovus Financial Corp." (SNV) at Buy with Decreased Target from $46 to $36 on, Apr 6th, 2023.
Michael has made no other calls on SNV in the last 4 months.
There are 3 other peers that have a rating on SNV. Out of the 3 peers that are also analyzing SNV, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Manan Gosalia of "Morgan Stanley" Maintained at Hold with Decreased Target to $30 on, Wednesday, April 5th, 2023
- Ryan Nash of "Goldman Sachs" Maintained at Hold with Decreased Target to $39 on, Thursday, March 30th, 2023
This is the rating of the analyst that currently disagrees with Michael
- Steven Alexopoulos of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Tuesday, December 13th, 2022
